Nov 11 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd 600196.SS:
SAYS UNIT HAS SOLD 1.095 MILLION ORDINARY SHARES OF BIONTECH FOR $179 MILLION BETWEEN MARCH 14 AND NOV 10
SAYS UNIT OWNS 485,878 ORDINARY SHARES, OR 0.20% STAKE, OF BIONTECH AFTER THE TRANSACTIONS
SAYS THE PROCEEDS WILL BE USED TO REPLENISH WORKING CAPITAL OF THE GROUP
SAYS THE SALE WILL NOT AFFECT COOPERATION BETWEEN THE GROUP AND BIONTECH AT BUSINESS LEVEL
Further company coverage: 600196.SS, 2196.HK 22UAy.DE
(Reporting by Hong Kong )
((twinnie.siu@tr.com; 852-3462 7715;))
All Comments
BUZZ-U.S. STOCKS ON THE MOVE-Loar, Regeneron, Intel
BUZZ-Pfizer, BioNTech fall as GSK sues over COVID-19 vaccine technology
UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology